99 related articles for article (PubMed ID: 16021601)
1. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells.
Hudrisier D; Riond J; Garidou L; Duthoit C; Joly E
Eur J Immunol; 2005 Aug; 35(8):2284-94. PubMed ID: 16021601
[TBL] [Abstract][Full Text] [Related]
2. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
3. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
Riond J; Elhmouzi J; Hudrisier D; Gairin JE
Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
5. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing.
Su MW; Pyarajan S; Chang JH; Yu CL; Jin YJ; Stierhof YD; Walden P; Burakoff SJ
Eur J Immunol; 2004 Sep; 34(9):2459-70. PubMed ID: 15307178
[TBL] [Abstract][Full Text] [Related]
6. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
7. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
[TBL] [Abstract][Full Text] [Related]
8. Chemical labels metabolically installed into the glycoconjugates of the target cell surface can be used to track lymphocyte/target cell interplay via trogocytosis: comparisons with lipophilic dyes and biotin.
Daubeuf S; Aucher A; Sampathkumar SG; Preville X; Yarema KJ; Hudrisier D
Immunol Invest; 2007; 36(5-6):687-712. PubMed ID: 18161525
[TBL] [Abstract][Full Text] [Related]
9. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
10. T cell avidity determines the level of CTL activation.
Hofmann M; Radsak M; Rechtsteiner G; Wiemann K; Günder M; Bien-Gräter U; Offringa R; Toes RE; Rammensee HG; Schild H
Eur J Immunol; 2004 Jul; 34(7):1798-806. PubMed ID: 15214028
[TBL] [Abstract][Full Text] [Related]
11. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
12. Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo.
Rechtsteiner G; Warger T; Hofmann M; Rammensee HG; Schild H; Radsak MP
Eur J Immunol; 2006 Oct; 36(10):2613-23. PubMed ID: 16955523
[TBL] [Abstract][Full Text] [Related]
13. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
14. Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes.
Auphan-Anezin N; Mazza C; Guimezanes A; Barrett-Wilt GA; Montero-Julian F; Roussel A; Hunt DF; Malissen B; Schmitt-Verhulst AM
Eur J Immunol; 2006 Jul; 36(7):1856-66. PubMed ID: 16761314
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
Klein I; Gassel HJ; Crispe IN
Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
[TBL] [Abstract][Full Text] [Related]
17. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
18. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
19. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
[TBL] [Abstract][Full Text] [Related]
20. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
Koide T; Iinuma H; Fukushima R
Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
